US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow
By Blake Brittain
WASHINGTON, May 28 (Reuters) - A U.S. appeals court on
Thursday overturned a $452 million verdict that medical device
maker Insulet PODD.O won against Korean rival EOFlow
294090.KQ for allegedly stealing trade secrets related to its
insulin-pump technology.
(Reporting by Blake Brittain in Washington)
((blake.brittain@tr.com; +1 (202) 938-5713))Recent news on EOFlow
See all newsUS court overturns Insulet's $59 million insulin-pump trade secret verdict against EOFlow (updated)
Corrected: US court overturns Insulet's $59 mln insulin-pump trade secret verdict against EOFlow
Corrected: UPDATE 1-US court overturns Insulet's $59 mln insulin-pump trade secret verdict against EOFlow
US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow
Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case